Organ Transplant Immunology: Clinical Perspectives and Challenges in Antibody Mediated Rejection
A special issue of Journal of Personalized Medicine (ISSN 2075-4426). This special issue belongs to the section "Clinical Medicine, Cell, and Organism Physiology".
Deadline for manuscript submissions: closed (5 December 2023) | Viewed by 159
Special Issue Editors
Interests: transplant immunology; antibody mediated rejection; ischemia reperfusion; transplant infection
Interests: antibody mediated rejection; pediatric kidney transplantation
Special Issue Information
Dear Colleagues,
The mechanism of rejection in transplantation immunology has gradually been revealed with progress in the field, but the mechanism of antibody-mediated rejection has not been fully clarified. Moreover, the diagnostic criteria for AMR are updated year-by-year, and are a hot topic in the clinical field of transplantation. Although there are many therapeutic methods for antibody-mediated rejection, their therapeutic effects are still not satisfactory. In recent years, a variety of treatment plans have been developed for active and chronic AMR. We must further summarize the effects of their clinical application and address future development in this field in terms of molecular mechanisms, diagnostic criteria, therapeutic drugs and methods, long-term effects, and other aspects.
Dr. Tao Qiu
Dr. Longshan Liu
Dr. Chenguang Ding
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Personalized Medicine is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- organ transplantation
- antibody-mediated rejection
- B cell
- HLA antibody
- non-HLA antibody
- plasma cell
